Lysergic Acid Diethylamide (LSD) antibody
-
- Target See all Lysergic Acid Diethylamide (LSD) Antibodies
- Lysergic Acid Diethylamide (LSD)
- Reactivity
- Please inquire
-
Host
-
Sheep
-
Clonality
- Polyclonal
-
Conjugate
- Un-conjugated
- Application
- ELISA, Immunohistochemistry (IHC), Western Blotting (WB), Dot Blot (DB), Immunoassay (IA)
- Purification
- Ig Fraction
- Immunogen
- LSD(8)-BSA
- Top Product
- Discover our top product LSD Primary Antibody
-
-
- Application Notes
- 20 µg/mL (EIA)
- Restrictions
- For Research Use only
-
- Format
- Liquid
- Concentration
- 11.06 mg/mL (U.V. abs at 280 nm)
- Buffer
- 20 mM Phosphate, 150 mM NaCl
- Storage
- 4 °C
-
- Target
- Lysergic Acid Diethylamide (LSD)
- Alternative Name
- LSD (LSD Products)
- Synonyms
- DHP2 antibody, DNAS1L3 antibody, LSD antibody, SLEB16 antibody, deoxyribonuclease 1 like 3 antibody, deoxyribonuclease 1-like 3 antibody, lymphocyte stimulating determinant antibody, DNASE1L3 antibody, Dnase1l3 antibody, Lsd antibody
- Target Type
- Chemical
- Background
- Lysergic acid diethylamide (LSD) is a highly potent hallucinogenic drug. It was first synthesized in 1938 from lysergic acid which was derived from ergot, a fungus found growing wild on rye and other grasses.
-